Literature DB >> 22133556

Comparison of in vivo bioluminescence imaging and lavage biomarkers to assess pulmonary inflammation.

Suzana Hadina1, Christine L Wohlford-Lenane, Peter S Thorne.   

Abstract

Gram-negative bacterial endotoxin triggers innate immunity via TLR-4 and NF-kB signal activation. The aim of this study was to evaluate the use of transgenic mice expressing luciferase as a marker of NF-kB activation for exploring innate immune responses to pulmonary endotoxin exposure over time thus obviating the need for serial necropsies. Transgenic rNF-kB-Luc BALB/c mice were exposed to two different types of endotoxin (Neisseria meningitidis lipooligosaccharide, and Escherichia coli lipopolysaccharide) at multiple doses by nasal instillation. Bioluminescence was quantified in vivo at five time points in three separate experiments. In the fourth experiment lungs were imaged ex vivo 8h post exposure and tissue was analyzed for luciferase activity. Non-transgenic BALB/c mice were similarly exposed to lipooligosaccharide and bronchoalveolar lavage was assessed for neutrophil recruitment and IL-6. Non-transgenic BALB/c mice exhibited highly significant increases of IL-6 and neutrophils in bronchoalveolar lavage 4h after the exposure to instilled doses as low as 30EU/mouse. In contrast, luciferase imaging of NF-kB signal activation in vivo in transgenic rNF-kB-Luc mice did not show significant changes over time or over doses from 30EU to 300,000EU/mouse of nasally-instilled endotoxin. Ex vivo lung imaging 8h after endotoxin exposure to 3000EU demonstrated a strong signal. An intravenous LPS dose of 300,000EU/mouse produced a measurable luminescence signal in vivo. This non-terminal assessment method is useful only with extremely high doses of endotoxin that induce systemic injury and cannot be applied to research of occupational and environmental exposures at relevant levels of endotoxin.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133556      PMCID: PMC3250089          DOI: 10.1016/j.tox.2011.11.009

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  15 in total

1.  In vivo imaging of NF-kappa B activity.

Authors:  Harald Carlsen; Jan Ø Moskaug; Sigurd H Fromm; Rune Blomhoff
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

2.  Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation.

Authors:  P S Thorne; P B McCray; T S Howe; M A O'Neill
Journal:  Am J Respir Cell Mol Biol       Date:  1999-06       Impact factor: 6.914

3.  Differential NF-kappaB activation after intratracheal endotoxin.

Authors:  T S Blackwell; L H Lancaster; T R Blackwell; A Venkatakrishnan; J W Christman
Journal:  Am J Physiol       Date:  1999-10

4.  Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice.

Authors:  M Manthorpe; F Cornefert-Jensen; J Hartikka; J Felgner; A Rundell; M Margalith; V Dwarki
Journal:  Hum Gene Ther       Date:  1993-08       Impact factor: 5.695

5.  Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia.

Authors:  Guang Yang; Aida Abate; Adia G George; Yi-Hao Weng; Phyllis A Dennery
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

6.  Caught in the act: in vivo molecular imaging of the transcription factor NF-kappaB after myocardial infarction.

Authors:  Jochen Tillmanns; Harald Carlsen; Rune Blomhoff; Guro Valen; Laura Calvillo; Georg Ertl; Johann Bauersachs; Stefan Frantz
Journal:  Biochem Biophys Res Commun       Date:  2006-02-17       Impact factor: 3.575

7.  Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo.

Authors:  Fiona E Yull; Wei Han; E Duco Jansen; M Brett Everhart; Ruxana T Sadikot; John W Christman; Timothy S Blackwell
Journal:  J Histochem Cytochem       Date:  2003-06       Impact factor: 2.479

8.  Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation.

Authors:  Ruxana T Sadikot; Wei Han; M Brett Everhart; Ornella Zoia; R Stokes Peebles; E Duco Jansen; Fiona E Yull; John W Christman; Timothy S Blackwell
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

9.  In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma.

Authors:  Paxton V Dickson; Blair Hamner; Catherine Y C Ng; Marshall M Hall; Junfang Zhou; Phillip W Hargrove; M Beth McCarville; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2007-07       Impact factor: 2.545

10.  Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice.

Authors:  Tin-Yun Ho; Yueh-Sheng Chen; Chien-Yun Hsiang
Journal:  Biomaterials       Date:  2007-07-23       Impact factor: 12.479

View more
  1 in total

1.  Evaluation of planar bioluminescence imaging and microPET/CT for therapy monitoring in a mouse model of pigmented metastatic melanoma.

Authors:  Ewa Pasquereau-Kotula; Benoit Hosten; Fortune Hontonnou; Nicolas Vignal; Florent Antoni; Jean-Luc Poyet; Nathalie Rizzo-Padoin; Laure Sarda-Mantel
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.